Our first priority is the health, wellness and safety of everyone who walks through our doors.

Bryn Mawr Medical Specialists Association is open for medically necessary office visits and procedures only. BMMSA as a corporation is taking all necessary precautions and following public health safety guidelines in regards to the COVID-19 pandemic.

TeleMedicine appointments are now available. Please contact your physicians office for eligibility, additional information, and with any concerns or questions.

As per order of the Commonwealth of Pennsylvania, any person entering our office building is required to wear a face mask at all times. Patients will not be permitted to enter the building without a face mask.

All patients should expect to be phone screened by Bryn Mawr Medical Specialists Association staff for COVID-19 symptoms or exposures prior to their appointment and again upon arrival. Patients should also expect to be temperature screened upon arrival in the office.

If your answer to any of the following questions is “Yes”, we ask that you call to reschedule your appointment.

In the past 14 days, have you developed any fever, cough or shortness of breath?
In the past 14 days, have you developed any of the following new symptoms?

  • Body aches or muscle pains?
  • Chills or repeated shaking with chills?
  • Headache?
  • Sore throat?
  • New loss of taste or of smell?
  • Have you, or anyone you have close contact with, been recently referred for COVID-19 testing?

In the past 14 days, have you traveled outside of PA? If “Yes”, please call the office to notify us of travel BEFORE your appointment. Patients recently returning from travel restricted states or countries will be asked to reschedule their appointment.

For the safety of our staff and other patients, patient family members or companions are not permitted at this time to accompany patients to their appointments (unless medically necessary or the patient is a minor). Bryn Mawr Medical Specialists Association respectfully asks family members or companions to wait outside or safely in their vehicle.

We encourage all of our patients to visit the CDC website and Main Line Health COVID-19 Response website to read more about everyday preventative measures and for the most up to date guidance regarding the Coronavirus (COVID-19). If you are concerned that you may have the Coronavirus (COVID-19), please contact your local Health Departments.

If you have any questions regarding our policy and your appointment, please call your doctor’s office.

Michael D. Gober, M.D., Ph. D.



  • American Board of Dermatology

    Board Certified 2012


Bryn Mawr Medical Arts Pavilion
825 Old Lancaster Road
Suite 450
Bryn Mawr, PA 19010

6 Lancaster Ave.
Wynnewood, PA 19096

Phone: (610) 642-1090
Fax: (610) 658-5861

Education & Training


  • 1994-1998 Cornell University, Ithaca, NY
    BA Biology, Concentration in Biochemistry
    Magna Cum Laude
  • 1998-2007 University of Maryland, School of Medicine, Baltimore, MD
    Combined MD/PhD program
    PhD–2006 in Department of Pharmacology and Experimental Therapeutics

Post-Graduate Training

  • 6/2007- 6/2008 Internship – Pennsylvania Hospital, Department of Medicine, Philadelphia, PA
  • 7/2008 –6/2011 Dermatology Residency – Hospital of the University of Pennsylvania, Philadelphia, PA

Research Grants, Honors, and Awards

  • 2017 Duhring Clinic Attending of the Year
    For Excellence in Teaching at University of Pennsylvania, Dept of Dermatology
  • 2016 Main Line Today – “Top Doc” in Dermatology
    Voting done by area health care providers
  • 3/2014 The Dr. Alfred W. Kopf Research Grant Award from the Skin Cancer Foundation
  • 7/2013-6/2015 Dermatology Foundation Physician Scientist Career Development Award
  • 7/2012-6/2013 UPenn SDRC (Skin Disease Research Center) Pilot and Feasability mini-grant award
  • 2007 Eugene Sydney Bereston Award for Excellence in Dermatology
    University of Maryland, School of Medicine
  • 2007 Election to Phi Kappa Phi Honor Society
  • 2006 Young Investigator Award–1st place
    Joint meeting of Experimental Contact Dermatitis Research Group and American Contact Dermatitis Society, Baltimore, MD
  • 2005, 2006 Margaret A. Hicks Scholarship Fund award recipient
    University of Maryland, School of Medicine
  • 2002-2004 Ruth L. Kirschstein National Research Service Award trainee
  • 2004 Oral presentation excellence award
    29th Annual International Herpesvirus Workshop, Reno, NV
  • 2000; 2001 University of Maryland Graduate Merit Award
  • 1996; 1997 Howard Hughes Undergraduate Scholar
    Cornell University

Book Chapters

  1. Gober MD, Treat J. Chapter 127 – Nutritional Dermatoses. In: Netter’s Pediatrics (Eds: Florin T and Ludwig S); Philadelphia PA Elsevier; 2011
  2. Gober MD, DeCapite TJ, Gaspari AA. Chapter 63 — Contact Dermatitis. In: Middleton’s Allergy 7th Edition Principles and Practice (Eds: Adkinson NF, Busse WW, Bochner BS, Holgate ST, Simons FER, and Lemanske RF); Philadelphia PA, Elsevier; 2009:1105-1116.

Selected Publications

  1. Gober MD, Bashir HM, Seykora JT. (2013). Reconstructing skin cancers using animal models. Cancer Metastasis Rev. 32:123-8.
  2. Ratushny V, Gober MD, Hick R, Ridky T , Seykora JT. (2012) From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest. 122:464-472
  3. Agi C, Gober MD, Ferenczi K, Takach P, Eagle RC, Rosenbach M. (2011) A Case of adult onset asthma with periocular xanthogranuloma. Arch Dermol. 147:1230-1
  4. Gober MD, Fishelevich R, Zhao Y, Unutmaz D, Gaspari AA. (2008) Human Natural Killer T Cells Infiltrate into the Skin at Elicitation Sites of Allergic Contact Dermatitis. J Invest Dermatol 128:1460-1469.
  5. Gober MD, Laing JM, Burnett JW, and Aurelian L (2007). The HSV gene Pol expressed in Herpes associated erythema multiforme (HAEM) lesions upregulates/activates SP1 and inflammatory cytokines Dermatology 215:97-106.
  6. Gober MD*, Rady PL*, He Q, Tucker SB, Tyring SK, Gaspari AA (2007). Novel homozygous frameshift mutation of EVER1 gene in an epidermodysplasia verruciformis patient. J Invest Dermatol 127:817-820. *Authors contributed equally to this work
  7. Gober MD, Laing JM, Thompson SM, and Aurelian L (2006). The growth compromised HSV-2 mutant ∆RR prevents kainic acid induced apoptosis and loss of function in organotypic hippocampal cultures. Brain Res 1119:26-39.
  8. Laing JM*, Gober MD*, Golembewski EK, Yarowsky PJ, Thompson SM, Gyure KA, and Aurelian L (2006). Intranasal administration of the growth compromised HSV-2 vector ΔRR prevents kainic acid induced seizures and neuronal loss in rats and mice. Mol Ther 13:870-881.
    *Authors contributed equally to this work
  9. Gober MD, Wales SQ, Hunter JCR, Sharma BK and Aurelian L (2005). Stress upregulates neuronal expression of the HSV-2 large subunit of ribonucleotide reductase (R1; ICP10) by activating AP-1. J Neurovirol 11:329-336.
  10. Gober MD, Smith CC, Ueda K, Toretsky JA, and Aurelian L (2003). Forced expression of the H11 heat shock protein can be regulated by DNA methylation and trigger apoptosis in human cells. J Biol Chem 278: 37600-37609.

Selected Abstracts/Presentations

  1. Gober M, Yang X, Li J, Huang A, Bashir H, Marshall C, Ridky T, and Seykora J. Voriconazole promotes UV-DNA damage by increasing oxidative stress. Poster presentation at Society of Investigative Dermatology Annual Meeting, Albuquerque, NM 2014
  2. Gober MD, Ferenczi K, Rosenbach M. A case of adult onset asthma with periocular xanthogranuloma. Presented in the Gross and Microscopic Symposium at the American Academy of Dermatology 69th Annual Meeting, New Orleans, LA 2011.
  3. Gober MD. Interesting cases from the University of Pennsylvania. Presented at Keio University Department of Dermatology Grand Rounds, Tokyo, Japan 2010
  4. Gober MD, Fishelevich R, Malinina A, Gaspari AA. Skin infiltration of NKT cells during the elicitation phase of human allergic contact dermatitis. Presented at 2006 Joint Meeting of the Experimental Contact Dermatitis Research Group and American Contact Dermatitis Society, Baltimore, MD
  5. Gober MD, Laing JM, Burnett JW, Aurelian L. Role of the HSV gene Pol in the pathogenesis of herpes associated erythema multiforme (HAEM). Poster #759 at 67th Annual Meeting of the Society for Investigative Dermatology, Philadelphia, PA 2006 J Invest Dermatol. 126(4):127.
  6. Gober MD, Thompson SM, and Aurelian L. HSV-2 ICP10PK protects organotypic hippocampal cultures from kainate induced excitotoxic insult by activating the ERK and AKT pathways. Abstract #2741 at XIII International Congress of Virology, the International Union of Microbiological Societies. San Francisco, CA 2005
  7. Gober MD, Thompson SM, Yarowsky P, and Aurelian L. ICP10PK protects from kainate induced apoptosis in organotypic hippocampal slice cultures through activation of the ERK survival pathway. Poster and oral presentation # 7.02 at 29th annual International Herpesvirus Workshop in Reno, NV, 2004
  8. Gober M, Smith C, Ueda K, and Aurelian L. H11 is a heat shock protein with apoptotic activity in melanoma. Poster 880-B40 at 42nd annual meeting of the American Society for Cell Biology in San Francisco, CA. 2002.
  9. Gober M, Smith C, He R, and Aurelian L. H11 is a candidate tumor suppressor with apoptosis modulating activity in melanoma. Oral presentation at 17th annual meeting of the National MD/PhD Conference in Aspen/Snowmass, CO. 2002

Professional Society Membership

2008 – present American Academy of Dermatology


  • University of Pennsylvania, Perelman School of Medicine — Clinical Associate in Dermatology
  • Philadelphia VA Medical Center — Dermatology Clinical Attending
Browse available departments: